Suppr超能文献

部分肾切除术与根治性肾切除术相比,与临床 T1 期肾细胞癌病理升级为 T3a 的患者复发风险更高。

Partial Nephrectomy is Associated with Higher Risk of Relapse Compared with Radical Nephrectomy for Clinical Stage T1 Renal Cell Carcinoma Pathologically Up Staged to T3a.

机构信息

Department of Urology, Smith Institute for Urology, Northwell Health, New Hyde Park, New York.

Department of Urology, University of Illinois at Chicago, Chicago, Illinois.

出版信息

J Urol. 2017 Aug;198(2):289-296. doi: 10.1016/j.juro.2017.03.012. Epub 2017 Mar 6.

Abstract

PURPOSE

We studied recurrence-free survival after partial vs radical nephrectomy for clinical stage T1 renal cell carcinoma in all patients and in those up staged to pathological stage T3a.

MATERIALS AND METHODS

We retrospectively reviewed the records of 1,250 patients who underwent partial or radical nephrectomy for clinically localized T1 renal cell carcinoma between 2006 and 2014. Recurrence-free survival was estimated using the Kaplan-Meier method and evaluated as a function of nephrectomy type with the log rank test and Cox models, adjusting for clinical, radiological and pathological characteristics.

RESULTS

A total of 86 recurrences (7%) were observed during a median followup of 37 months. No difference in recurrence-free survival between partial and radical nephrectomy was found among all clinical stage T1 renal cell carcinomas. T3a up staging was noted in 140 patients (11%) and recurrent disease was observed in 44 (31.4%) during a median followup of 38 months. Among up staged T3a cases partial nephrectomy was associated with shorter recurrence-free survival compared to radical nephrectomy on univariable analysis (recurrence HR 2.04, 95% CI 1.12-3.68, p = 0.019) and multivariable analysis (recurrence HR 5.39, 95% CI 1.94-14.9, p = 0.001).

CONCLUSIONS

In a subgroup of patients clinically staged T1 renal cell carcinoma will be pathologically up staged to T3a. Among these patients those who undergo partial nephrectomy appear to have inferior recurrence-free survival relative to those who undergo radical nephrectomy.

摘要

目的

我们研究了在所有患者和分期为病理 T3a 的患者中,局限性 T1 期肾细胞癌行部分肾切除术与根治性肾切除术的无复发生存率。

材料和方法

我们回顾性分析了 2006 年至 2014 年间接受部分或根治性肾切除术治疗局限性 T1 期肾细胞癌的 1250 例患者的记录。采用 Kaplan-Meier 法估计无复发生存率,并采用对数秩检验和 Cox 模型评估与肾切除术类型的关系,调整临床、影像学和病理学特征。

结果

在中位随访 37 个月期间,共观察到 86 例(7%)复发。在所有临床分期 T1 期肾细胞癌中,部分肾切除术与根治性肾切除术之间无无复发生存率差异。140 例(11%)患者分期为 T3a,在中位随访 38 个月期间,44 例(31.4%)患者出现复发。在 T3a 分期病例中,单变量分析显示部分肾切除术与根治性肾切除术相比,无复发生存率较短(复发 HR 2.04,95%CI 1.12-3.68,p=0.019),多变量分析显示(复发 HR 5.39,95%CI 1.94-14.9,p=0.001)。

结论

在一组临床分期为 T1 期肾细胞癌的患者中,将有病理分期为 T3a 的患者。在这些患者中,与接受根治性肾切除术的患者相比,接受部分肾切除术的患者无复发生存率较低。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验